Total RNAs from MDA-MB-231 (high aggressive), MDA-MB-468 (medium aggressive) and MCF-7 (low aggressive) breast cancer cells cultured in serum-free medium or in complete culture medium were reverse transcribed and amplified using specific primers for serglycin (Fig. 2B). This evidence concerns the gene SRGN and breast cancer.